D. Marissens

627 total citations
13 papers, 399 citations indexed

About

D. Marissens is a scholar working on Infectious Diseases, Virology and Animal Science and Zoology. According to data from OpenAlex, D. Marissens has authored 13 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 7 papers in Virology and 3 papers in Animal Science and Zoology. Recurrent topics in D. Marissens's work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (5 papers). D. Marissens is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (5 papers). D. Marissens collaborates with scholars based in Belgium, United States and France. D. Marissens's co-authors include Georges Zissis, S. Lauwers, J.P. Lambert, Patrick Lacor, Nathan Clumeck, Hilde Revets, Jack Lévy, Marc Hainaut, Cécile Peltier and Katrien Fransen and has published in prestigious journals such as Journal of Virology, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

D. Marissens

13 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Marissens Belgium 11 342 202 96 66 50 13 399
Tamara Bar-Magen Canada 13 508 1.5× 387 1.9× 84 0.9× 84 1.3× 112 2.2× 16 668
C Jayavasu Thailand 9 329 1.0× 129 0.6× 83 0.9× 81 1.2× 116 2.3× 14 374
J C Bouquety Central African Republic 9 182 0.5× 52 0.3× 45 0.5× 36 0.5× 64 1.3× 11 329
Saskia Weber Germany 10 177 0.5× 105 0.5× 150 1.6× 60 0.9× 20 0.4× 22 392
William A. Charini United States 13 200 0.6× 535 2.6× 162 1.7× 13 0.2× 57 1.1× 15 776
Hugues Loemba Canada 9 310 0.9× 161 0.8× 44 0.5× 154 2.3× 16 0.3× 24 369
I Vodopija Croatia 10 101 0.3× 162 0.8× 172 1.8× 18 0.3× 25 0.5× 31 293
Jonathan Hubb United Kingdom 5 175 0.5× 26 0.1× 76 0.8× 58 0.9× 36 0.7× 5 216
Subhash V. Kapre India 13 146 0.4× 60 0.3× 309 3.2× 15 0.2× 16 0.3× 24 429
Songsri Kasempimolporn Thailand 10 97 0.3× 143 0.7× 116 1.2× 11 0.2× 18 0.4× 25 274

Countries citing papers authored by D. Marissens

Since Specialization
Citations

This map shows the geographic impact of D. Marissens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Marissens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Marissens more than expected).

Fields of papers citing papers by D. Marissens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Marissens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Marissens. The network helps show where D. Marissens may publish in the future.

Co-authorship network of co-authors of D. Marissens

This figure shows the co-authorship network connecting the top 25 collaborators of D. Marissens. A scholar is included among the top collaborators of D. Marissens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Marissens. D. Marissens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bel, Annelies De, et al.. (2010). Correction of Underquantification of Human Immunodeficiency Virus Type 1 Load with the Second Version of the Roche Cobas AmpliPrep/Cobas TaqMan Assay. Journal of Clinical Microbiology. 48(4). 1337–1342. 20 indexed citations
2.
Bertrand, Édouard, Georges Zissis, D. Marissens, et al.. (2004). Presence of HIV-1 in follicular fluids, flushes and cumulus oophorus cells of HIV-1-seropositive women during assisted-reproduction technology. AIDS. 18(5). 823–825. 14 indexed citations
3.
Hainaut, Marc, Liliane Schandené, Cécile Peltier, et al.. (2003). Age-related immune reconstitution during highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children. The Pediatric Infectious Disease Journal. 22(1). 62–69. 34 indexed citations
4.
Vaerenbergh, Kristien Van, Inge Derdelinckx, Nancy De Cabooter, et al.. (2001). Retrospective analysis of therapy response to the initial therapy in 91 treatment-naive HIV-1 patients with and without baseline resistance mutations as measured by LiPA. Antiviral Therapy. 6. 96. 1 indexed citations
5.
Vaerenbergh, Kristien Van, Nancy De Cabooter, K. Desmet, et al.. (2001). Prevalence of Genotypic Resistance among Antiretroviral Drug-Naive HIV-1-Infected Patients in Belgium. Antiviral Therapy. 6(1). 63–70. 36 indexed citations
6.
Muyldermans, Gaëtan, Katrien Fransen, D. Marissens, et al.. (2000). Blinded, multicenter quality control study for the quantification of human immunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories. Clinical Microbiology and Infection. 6(4). 213–217. 17 indexed citations
7.
Hainaut, Marc, Cécile Peltier, Michèle Gérard, et al.. (2000). Effectiveness of antiretroviral therapy initiated before the age of 2 months in infants vertically infected with human immunodeficiency virus type 1. European Journal of Pediatrics. 159(10). 778–782. 37 indexed citations
8.
Revets, Hilde, D. Marissens, Patrick Lacor, et al.. (1996). Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma. Journal of Clinical Microbiology. 34(5). 1058–1064. 89 indexed citations
9.
Fransen, Katrien, D. Marissens, Rita Verhelst, et al.. (1996). Isolation of HIV-1 RNA from plasma: evaluation of eight different extraction methods. Journal of Virological Methods. 60(2). 155–159. 40 indexed citations
10.
Lambert, J.P., et al.. (1984). Monoclonal antibodies directed against different antigenic determinants of rotavirus. Journal of Virology. 51(1). 47–51. 21 indexed citations
11.
Zissis, Georges, et al.. (1983). Prevalence of neutralizing antibodies against a candidate rotavirus vaccine in adults.. PubMed. 53. 201–8. 1 indexed citations
12.
Lambert, J.P., et al.. (1983). Prevalence of subgroup 1, 2, and 3 rotaviruses in belgian children suffering from acute diarrhea (1978–1981). Journal of Medical Virology. 11(1). 31–38. 33 indexed citations
13.
Zissis, Georges, J.P. Lambert, D. Marissens, et al.. (1983). Protection Studies in Colostrum-Deprived Piglets of a Bovine Rotavirus Vaccine Candidate Using Human Rotavirus Strains for Challenge. The Journal of Infectious Diseases. 148(6). 1061–1068. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026